Clinical Trial Update: Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating rosuvastatin therapy for lowering LDL-C in patients with hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesteremia | Phase 3 | Status: COMPLETED